glp-1 alzheimer's 2024 A doctor explains why weight loss medications may do more than change the scale—early research suggests they could sharply cut risk by easing inflammation and protecting the brain GLP-1 Microdosing, Brain Health &
Description
New research clearly shows that non-diabetic people face high gastroparesis risks when they use GLP-1 agonists
PLoS Med 2009;6:e1000097
29 A prospective, nonrandomised pilot study conducted by Campforts et al
The benefits of these medications for glycaemic control and cardiovascular risk reduction generally outweigh the potential pancreatic risks in appropriately selected patients
More is not always better, McGowan said
Rushing the escalation means three pathways adapting at once, which multiplies the potential for GI distress
